A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 1,431 shares of BIO stock, worth $468,609. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,431
Holding current value
$468,609
% of portfolio
0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $377,741 - $493,179
1,431 New
1,431 $479 Million
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $608 - $703
2 New
2 $537,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.07B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.